L1CAM and neurodegenerative disease: For NEV marker selection, we analyzed a recent systematic review that focused on the enrichment of NEVs from the blood of neurodegenerative disease patients.[24] This review evaluated publications over the past decade, with a primary emphasis on NEV enrichment from blood via immunoprecipitation, and identified L1CAM as the most commonly used marker for isolating NEVs.